James M. Daly, Director at HALOZYME THERAPEUTICS, INC. (HALO), sold 20,726 shares at $40.41 ($838K) on 2020-11-25, disclosed to the SEC on 2020-11-25.
Open-market sale of $838k HALO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.41 | 10,363 | $419K | 50.0% |
| 2 | $40.41 | 10,363 | $419K | 50.0% |
| Total | $40.41 avg | 20,726 | $838K | 100% |
| Filing → |
| MDGL | SELL | 2024-04-03 | $15.9M | — | Filing → |
| HALO | SELL | 2023-08-15 | $875K | — | Filing → |
| HALO | SELL | 2020-08-13 | $2.0M | — | Filing → |